Want to learn more? Register for a webinar or to stay up-to-date on product availability.
New Ethiqa XR from Fidelis Pharmaceuticals is the first and only pharmaceutical grade extended-release buprenorphine proven effective in reducing pain for lab mice and rats up to 72 hours after administration of just one injection.
Coming soon through distributors…
Ethiqa XR will offer:
An Ethical Imperative
Effective pain management for laboratory animals is an essential need in today’s research. Learn more about industry association guidelines.